Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 27;10(11):807-821.
doi: 10.4254/wjh.v10.i11.807.

Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018

Affiliations
Review

Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018

Maléki Assih et al. World J Hepatol. .

Abstract

The severity of hepatic pathology and the response to treatment depend on the hepatitis virus genotype in the infected host. The objective of this review was to determine the distribution of hepatitis virus genotypes in West African countries. A systematic review of the literature in PubMed, Google Scholar and Science Direct was performed to identify 52 relevant articles reporting hepatitis A, B, C, D, E and G viruses genotypes. Hepatitis B virus (HBV) genotype E with a prevalence of 90.6% (95%CI: 0.891-0.920) found in this review, is characterized by low genetic diversity. Hepatitis C virus (HCV) genotypes 1 and 2 represented 96.4% of HCV infections in West African countries, while hepatitis delta virus, hepatitis A virus, hepatitis G virus genotypes 1 and HEV genotype 3 were reported in some studies in Ghana and Nigeria. HBV genotype E is characterized by high prevalence, low genetic diversity and wide geographical distribution. Further studies on the clinical implications of HBV genotype E and HCV genotypes 1 and 2 are needed for the development of an effective treatment against this viral hepatitis in West African countries. Surveillance of the distribution of different genotypes is also needed to reduce recombination rates and prevent the emergence of more virulent viral strains.

Keywords: Genotypes; Hepatitis virus; Mutations; Recombination; West African Economic and Monetary Union.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: No potential conflicts of interest. No financial support.

Figures

Figure 1
Figure 1
Flow diagram showing the method for the study selection. The database search for the search strategy described in the section was cleaned up to exclude review articles and duplicates. Titles and abstracts were included in the literature review. Seroprevalence articles, articles with ambiguous data that did not meet the inclusion criteria were then excluded during the full-text review. Fifty-two (52) relevant articles were finally included for this review.
Figure 2
Figure 2
Phylogenetic tree of 53 hepatitis B virus genotype E and A sequences identified in West African Economic and Monetary Union countries including Ghana and Nigeria (indicated ♦). Phylogenetic analysis was performed with the neighbor-joining algorithm based on the Kimura two-parameter distance estimation method. Only bootstrap values of > 80% are shown (1.000 replicates). Reference hepatitis B virus sequences (44) recovered from GenBank are denoted with their accession numbers and genotypes/sub-genotypes are indicated.
Figure 3
Figure 3
Hepatitis B virus genotypes reported in West African Economic and Monetary Union countries, Ghana and Nigeria. Pie charts show the proportion of different hepatitis B virus genotypes in West African countries according to the data in Table 1.
Figure 4
Figure 4
Hepatitis C virus genotypes reported in West African Economic and Monetary Union countries, Ghana and Nigeria. Pie charts show the proportion of different hepatitis B virus genotypes in West African countries according to the data in Table 2.

Similar articles

Cited by

References

    1. World Health Organization. Global Hepatitis Report, 2017. Available from: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
    1. Halasz R, Weiland O, Sällberg M. GB virus C/hepatitis G virus. Scand J Infect Dis. 2001;33:572–580. - PubMed
    1. Blackard JT, Ma G, Polen C, DuBois JC, Gast J, Radens CM, Sterling RK, Sherman KE. Recombination among GB virus C (GBV-C) isolates in the United States. J Gen Virol. 2016;97:1537–1544. - PMC - PubMed
    1. Tao I, Bisseye C, Nagalo BM, Sanou M, Kiba A, Surat G, Compaoré TR, Traoré L, Nikiema JB, Pietra V, et al. Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa. Mediterr J Hematol Infect Dis. 2013;5:e2013053. - PMC - PubMed
    1. World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Available from: http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/